Benitec Biopharma Inc
Research Benitec Biopharma Inc (BNTC) on Bullrun: market cap USD 305.28M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBNTC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 305.28M
- Financial periodFY2026
- RevenueUSD 0
- Net income-USD 45.55M
- Free cash flow-USD 16.62M
Valuation Snapshot
latest market cap is USD 305.28M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 0 | -USD 45.55M | -USD 16.62M | n/a | -0.98 | USD 179.97M | USD 762.00K | USD 177.01M |
| FY2025 | USD 0 | -USD 37.92M | -USD 23.61M | n/a | -1.05 | USD 97.74M | USD 849.00K | USD 97.30M |
| FY2024 | USD 0 | -USD 21.75M | -USD 19.58M | n/a | -1.22 | USD 50.87M | USD 284.00K | USD 47.25M |
| FY2023 | USD 75.00K | -USD 19.56M | -USD 18.01M | 100.0% | -14.12 | USD 2.48M | USD 559.00K | USD 202.00K |
| FY2022 | USD 73.00K | -USD 18.21M | -USD 15.91M | 87.7% | -37.88 | USD 4.06M | USD 811.00K | USD 2.88M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 305.28M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 461.41M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 296.19M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 8.31M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 4.76M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 21.41M | n/a | n/a | n/a |
About Benitec Biopharma Inc
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Benitec Biopharma Inc's market cap?
Benitec Biopharma Inc's market capitalization is USD 305.28M.
What does Benitec Biopharma Inc do?
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct.